Delivery Order SPE2DR25D2108-SPE2DR26F6RR6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with a ceiling value of $5,394.61. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement, with an ultimate completion date of December 10, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $66,535.75 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of July 30, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $39,150.40 to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count). This competitively awarded, firm fixed-price contract is set to be completed by November 19, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a $14,351.01 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $26,870.53 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by December 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,654.32 to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of December 11, 2025. The contract carries no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $64,939.14 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,172.61 to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This firm fixed-price delivery order, with an ultimate completion date of December 16, 2025, was competitively awarded with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $1,089.41. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement process. The order is set to reach completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RR6Delivery Order
The Defense Logistics Agency awarded a $23,626.87 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This competitively awarded, firm fixed-price contract has an ultimate completion date of December 18, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a primary pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies critical medications and medical supplies to support military healthcare programs and other government health systems. The Trelegy Ellipta product, a combination respiratory medication, supports the military health system's pharmaceutical needs and exemplifies the broad therapeutic portfolio AmerisourceBergen delivers through its comprehensive federal contract agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.6k | 12/16/25 |